Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aurora Spine's DEXA-C Cervical Interbodies Used in First Surgery - Orthopedic Design & Technology
OEM News

Aurora Spine’s DEXA-C Cervical Interbodies Used in First Surgery

DEXA-C implants are matched to the patient's bone density.

Spinal Implant maker Aurora Spine has completed its first DEXA-C cervical interbody fusion surgery at Louisiana’s Cypress Pointe Surgical Hospital. The implant density was directly matched with the patient’s bone quality.
 
“It’s a significant milestone for Aurora to announce the completion of the world’s first surgical implantations of the DEXA-C patient-bone-density matched interbody devices,” Aurora Spine president and CEO Trent Northcutt told the press. “The DEXA-C implants, a line of cervical cages for anterior cervical discectomy with fusion (ACDF) procedures, are the first of its kind in the world by offering an implant based upon a patient’s bone density. It is also the first color-coded implant on the marketplace and will help doctors match against the color-coding of a DEXA score.”
 
Aurora’s DEXA-C implants, according to the company, are the first of their kind to match bone density and quality to a customized implant. DEXA-C simulates human cancellous bone’s lattice structure with a similar modulus of elasticity, then specialized to match bone status across the bone mineral density (BMD) continuum. The implant’s pore compactness then directly corresponds to the patient’s DEXA-define BMD status, including those with osteoporosis.
 
“The DEXA-C implant from Aurora Spine ushers in a new era of personalized spine surgery,” said Dr. Sebastian Koga, Neurosurgeon at Koga Neurosurgery. “This customization prevents implant subsidence and accelerates fusion even in healthy individuals. This will expand access to spine surgery for older patients who were previously excluded by poor bone quality.”
 
Aurora Spine earned U.S. Food and Drug Administration (FDA) clearance for DEXA-C cervical interbodies in August 2021.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters